Monthly information on share capital and company voting rights

Rhea-AI Summary

Cellectis has reported its monthly share capital and voting rights information as of October 31, 2024. The company disclosed a total of 100,093,873 shares in the capital and 88,569,210 voting rights. This disclosure is made in compliance with Article 223-16 of the General Regulation of the French financial markets authority for its listing on Euronext Growth under ISIN code FR0010425595.

News Market Reaction – CLLS

-1.13%

1 alert

-1.13% News Effect

On the day this news was published, CLLS declined 1.13%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Nov. 06, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
10/31/2024	100,093,873	88,569,210

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com

Attachment

• Voting_Rights_PR_October_2024_EN

FAQ

How many shares does Cellectis (CLLS) have as of October 31, 2024?

Cellectis had 100,093,873 total shares in the capital as of October 31, 2024.

What is the total number of voting rights for Cellectis (CLLS) in October 2024?

Cellectis reported 88,569,210 total voting rights as of October 31, 2024.

On which exchange is Cellectis (CLLS) listed according to the October 2024 report?

Cellectis is listed on Euronext Growth market according to the October 2024 report.